Signalling Pathways 2016 – Personalised Medicine

ELCC 2016 – Lung Cancer

Mark you diaries now for ELCC 2016 in Geneva, Switzerland. 13-16 April 2016

IMPAKT 2016 – Breast Cancer

Save the date for the IMPAKT 2016 breast cancer conference: 12-14 May 2016

ESMO 2016 Congress

Mark you diaries now for ESMO 2016 in Copenhagen, Denmark. 7-11 October 2016

ESMO 2017 Congress

Save the date for ESMO 2017: 8-12 September 2017 in Madrid, Spain

Preceptorship Meetings

Educational events on specific topics or cancer types and aim to provide a learning experience and training for young oncologists

Workshops & Courses

ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.

Patient Guides

Our cervical cancer, endometrial cancer and ovarian cancer patient guides are now available in Italian

Personalised Medicine Explained

Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine

Getting the Most out of Your Oncologist

Now available in Greek, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.

Designated Centres of Integrated Oncology and Palliative Care

The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.

EFPIA Disclosure Code

ELCC 2014: Programme

The European Lung Cancer Conference is organised by top academic experts in lung cancer and thoracic malignancies from ESMO and IASLC.

The conference is relevant for medical oncologists, radiotherapists, thoracic surgeons, respiratory physicians, and other medical professionals involved in the diagnosis, treatment and follow-up of patients with lung cancer.

The lectures are designed to analyse and effectively interpret the increasing amount of new clinical data available for multidisciplinary treatment decisions in patients with lung cancer and other thoracic malignancies

Top expert faculty will do the best to determine the optimal roles of new diagnostics and therapeutics in clinical scenarios for the treatment of patients with early, locally-advanced and metastatic disease

CME accreditation

ESMO-MORA: The conference programme has been accredited with 23 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology.
See here for further details.

CME: The European Lung Cancer Conference will be submitted for accreditation to the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Information on the process to convert EACCME credit to AMA credit can be found online here.

Webcasts

The Conference webcasts will include all the session of the official programme, where speaker permission is granted, and will be available on this website and OncologyPro for ESMO members.